Autoimmune disease is a condition in which the immune system is unable to recognize the body?s own cells and starts attacking them. The immune system might attack different types of body cells, depending on which the autoimmune disease is classified. This disease might result in degradation as well as improper functioning of body organs.
This report aims to provide a comprehensive presentation of the global market for Autoimmune Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Disease Drug. This report contains market size and forecasts of Autoimmune Disease Drug in global, including the following market information:
Global Autoimmune Disease Drug Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Autoimmune Disease Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
NSAIDs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Autoimmune Disease Drug include Abbott Laboratories, Pfizer, AbbVie, Eli Lilly, Bristol-Myers Squibb, AstraZeneca plc, GlaxoSmithKline, Roche and Biogen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Autoimmune Disease Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Autoimmune Disease Drug Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Autoimmune Disease Drug Market Segment Percentages, by Type, 2022 (%)
NSAIDs
Anti-Inflammatory
Interferons
Antihyperglycemics
Others
Global Autoimmune Disease Drug Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Autoimmune Disease Drug Market Segment Percentages, by Application, 2022 (%)
Rheumatoid Arthritis
Type 1 Diabetes
Multiple Sclerosis
Psoriasis
Lupus
Inflammatory Bowel Disease
Others
Global Autoimmune Disease Drug Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Autoimmune Disease Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Autoimmune Disease Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Autoimmune Disease Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Pfizer
AbbVie
Eli Lilly
Bristol-Myers Squibb
AstraZeneca plc
GlaxoSmithKline
Roche
Biogen
Amgen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Autoimmune Disease Drug, market overview.
Chapter 2: Global Autoimmune Disease Drug market size in revenue.
Chapter 3: Detailed analysis of Autoimmune Disease Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Autoimmune Disease Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Autoimmune Disease Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Autoimmune Disease Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Autoimmune Disease Drug Overall Market Size
2.1 Global Autoimmune Disease Drug Market Size: 2022 VS 2030
2.2 Global Autoimmune Disease Drug Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Autoimmune Disease Drug Players in Global Market
3.2 Top Global Autoimmune Disease Drug Companies Ranked by Revenue
3.3 Global Autoimmune Disease Drug Revenue by Companies
3.4 Top 3 and Top 5 Autoimmune Disease Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Autoimmune Disease Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Autoimmune Disease Drug Players in Global Market
3.6.1 List of Global Tier 1 Autoimmune Disease Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Autoimmune Disease Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Autoimmune Disease Drug Market Size Markets, 2022 & 2030
4.1.2 NSAIDs
4.1.3 Anti-Inflammatory
4.1.4 Interferons
4.1.5 Antihyperglycemics
4.1.6 Others
4.2 By Type - Global Autoimmune Disease Drug Revenue & Forecasts
4.2.1 By Type - Global Autoimmune Disease Drug Revenue, 2018-2023
4.2.2 By Type - Global Autoimmune Disease Drug Revenue, 2024-2030
4.2.3 By Type - Global Autoimmune Disease Drug Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Autoimmune Disease Drug Market Size, 2022 & 2030
5.1.2 Rheumatoid Arthritis
5.1.3 Type 1 Diabetes
5.1.4 Multiple Sclerosis
5.1.5 Psoriasis
5.1.6 Lupus
5.1.7 Inflammatory Bowel Disease
5.1.8 Others
5.2 By Application - Global Autoimmune Disease Drug Revenue & Forecasts
5.2.1 By Application - Global Autoimmune Disease Drug Revenue, 2018-2023
5.2.2 By Application - Global Autoimmune Disease Drug Revenue, 2024-2030
5.2.3 By Application - Global Autoimmune Disease Drug Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Autoimmune Disease Drug Market Size, 2022 & 2030
6.2 By Region - Global Autoimmune Disease Drug Revenue & Forecasts
6.2.1 By Region - Global Autoimmune Disease Drug Revenue, 2018-2023
6.2.2 By Region - Global Autoimmune Disease Drug Revenue, 2024-2030
6.2.3 By Region - Global Autoimmune Disease Drug Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Autoimmune Disease Drug Revenue, 2018-2030
6.3.2 US Autoimmune Disease Drug Market Size, 2018-2030
6.3.3 Canada Autoimmune Disease Drug Market Size, 2018-2030
6.3.4 Mexico Autoimmune Disease Drug Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Autoimmune Disease Drug Revenue, 2018-2030
6.4.2 Germany Autoimmune Disease Drug Market Size, 2018-2030
6.4.3 France Autoimmune Disease Drug Market Size, 2018-2030
6.4.4 U.K. Autoimmune Disease Drug Market Size, 2018-2030
6.4.5 Italy Autoimmune Disease Drug Market Size, 2018-2030
6.4.6 Russia Autoimmune Disease Drug Market Size, 2018-2030
6.4.7 Nordic Countries Autoimmune Disease Drug Market Size, 2018-2030
6.4.8 Benelux Autoimmune Disease Drug Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Autoimmune Disease Drug Revenue, 2018-2030
6.5.2 China Autoimmune Disease Drug Market Size, 2018-2030
6.5.3 Japan Autoimmune Disease Drug Market Size, 2018-2030
6.5.4 South Korea Autoimmune Disease Drug Market Size, 2018-2030
6.5.5 Southeast Asia Autoimmune Disease Drug Market Size, 2018-2030
6.5.6 India Autoimmune Disease Drug Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Autoimmune Disease Drug Revenue, 2018-2030
6.6.2 Brazil Autoimmune Disease Drug Market Size, 2018-2030
6.6.3 Argentina Autoimmune Disease Drug Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Autoimmune Disease Drug Revenue, 2018-2030
6.7.2 Turkey Autoimmune Disease Drug Market Size, 2018-2030
6.7.3 Israel Autoimmune Disease Drug Market Size, 2018-2030
6.7.4 Saudi Arabia Autoimmune Disease Drug Market Size, 2018-2030
6.7.5 UAE Autoimmune Disease Drug Market Size, 2018-2030
7 Autoimmune Disease Drug Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Autoimmune Disease Drug Major Product Offerings
7.1.4 Abbott Laboratories Autoimmune Disease Drug Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Autoimmune Disease Drug Major Product Offerings
7.2.4 Pfizer Autoimmune Disease Drug Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Autoimmune Disease Drug Major Product Offerings
7.3.4 AbbVie Autoimmune Disease Drug Revenue in Global Market (2018-2023)
7.3.5 AbbVie Key News & Latest Developments
7.4 Eli Lilly
7.4.1 Eli Lilly Company Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Autoimmune Disease Drug Major Product Offerings
7.4.4 Eli Lilly Autoimmune Disease Drug Revenue in Global Market (2018-2023)
7.4.5 Eli Lilly Key News & Latest Developments
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Company Summary
7.5.2 Bristol-Myers Squibb Business Overview
7.5.3 Bristol-Myers Squibb Autoimmune Disease Drug Major Product Offerings
7.5.4 Bristol-Myers Squibb Autoimmune Disease Drug Revenue in Global Market (2018-2023)
7.5.5 Bristol-Myers Squibb Key News & Latest Developments
7.6 AstraZeneca plc
7.6.1 AstraZeneca plc Company Summary
7.6.2 AstraZeneca plc Business Overview
7.6.3 AstraZeneca plc Autoimmune Disease Drug Major Product Offerings
7.6.4 AstraZeneca plc Autoimmune Disease Drug Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca plc Key News & Latest Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Company Summary
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Autoimmune Disease Drug Major Product Offerings
7.7.4 GlaxoSmithKline Autoimmune Disease Drug Revenue in Global Market (2018-2023)
7.7.5 GlaxoSmithKline Key News & Latest Developments
7.8 Roche
7.8.1 Roche Company Summary
7.8.2 Roche Business Overview
7.8.3 Roche Autoimmune Disease Drug Major Product Offerings
7.8.4 Roche Autoimmune Disease Drug Revenue in Global Market (2018-2023)
7.8.5 Roche Key News & Latest Developments
7.9 Biogen
7.9.1 Biogen Company Summary
7.9.2 Biogen Business Overview
7.9.3 Biogen Autoimmune Disease Drug Major Product Offerings
7.9.4 Biogen Autoimmune Disease Drug Revenue in Global Market (2018-2023)
7.9.5 Biogen Key News & Latest Developments
7.10 Amgen
7.10.1 Amgen Company Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen Autoimmune Disease Drug Major Product Offerings
7.10.4 Amgen Autoimmune Disease Drug Revenue in Global Market (2018-2023)
7.10.5 Amgen Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Autoimmune Disease Drug Market Opportunities & Trends in Global Market
Table 2. Autoimmune Disease Drug Market Drivers in Global Market
Table 3. Autoimmune Disease Drug Market Restraints in Global Market
Table 4. Key Players of Autoimmune Disease Drug in Global Market
Table 5. Top Autoimmune Disease Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Autoimmune Disease Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Autoimmune Disease Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Autoimmune Disease Drug Product Type
Table 9. List of Global Tier 1 Autoimmune Disease Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Autoimmune Disease Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Autoimmune Disease Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Autoimmune Disease Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Autoimmune Disease Drug Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Autoimmune Disease Drug Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Autoimmune Disease Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Autoimmune Disease Drug Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Autoimmune Disease Drug Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Autoimmune Disease Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Autoimmune Disease Drug Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Autoimmune Disease Drug Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Autoimmune Disease Drug Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Autoimmune Disease Drug Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Autoimmune Disease Drug Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Autoimmune Disease Drug Revenue, (US$, Mn), 2024-2030
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Autoimmune Disease Drug Product Offerings
Table 32. Abbott Laboratories Autoimmune Disease Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Autoimmune Disease Drug Product Offerings
Table 36. Pfizer Autoimmune Disease Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. AbbVie Company Summary
Table 39. AbbVie Autoimmune Disease Drug Product Offerings
Table 40. AbbVie Autoimmune Disease Drug Revenue (US$, Mn) & (2018-2023)
Table 41. AbbVie Key News & Latest Developments
Table 42. Eli Lilly Company Summary
Table 43. Eli Lilly Autoimmune Disease Drug Product Offerings
Table 44. Eli Lilly Autoimmune Disease Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Eli Lilly Key News & Latest Developments
Table 46. Bristol-Myers Squibb Company Summary
Table 47. Bristol-Myers Squibb Autoimmune Disease Drug Product Offerings
Table 48. Bristol-Myers Squibb Autoimmune Disease Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Bristol-Myers Squibb Key News & Latest Developments
Table 50. AstraZeneca plc Company Summary
Table 51. AstraZeneca plc Autoimmune Disease Drug Product Offerings
Table 52. AstraZeneca plc Autoimmune Disease Drug Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca plc Key News & Latest Developments
Table 54. GlaxoSmithKline Company Summary
Table 55. GlaxoSmithKline Autoimmune Disease Drug Product Offerings
Table 56. GlaxoSmithKline Autoimmune Disease Drug Revenue (US$, Mn) & (2018-2023)
Table 57. GlaxoSmithKline Key News & Latest Developments
Table 58. Roche Company Summary
Table 59. Roche Autoimmune Disease Drug Product Offerings
Table 60. Roche Autoimmune Disease Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Roche Key News & Latest Developments
Table 62. Biogen Company Summary
Table 63. Biogen Autoimmune Disease Drug Product Offerings
Table 64. Biogen Autoimmune Disease Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Biogen Key News & Latest Developments
Table 66. Amgen Company Summary
Table 67. Amgen Autoimmune Disease Drug Product Offerings
Table 68. Amgen Autoimmune Disease Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Amgen Key News & Latest Developments
List of Figures
Figure 1. Autoimmune Disease Drug Segment by Type in 2022
Figure 2. Autoimmune Disease Drug Segment by Application in 2022
Figure 3. Global Autoimmune Disease Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Autoimmune Disease Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Autoimmune Disease Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Autoimmune Disease Drug Revenue in 2022
Figure 8. By Type - Global Autoimmune Disease Drug Revenue Market Share, 2018-2030
Figure 9. By Application - Global Autoimmune Disease Drug Revenue Market Share, 2018-2030
Figure 10. By Type - Global Autoimmune Disease Drug Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Autoimmune Disease Drug Revenue Market Share, 2018-2030
Figure 12. By Application - Global Autoimmune Disease Drug Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Autoimmune Disease Drug Revenue Market Share, 2018-2030
Figure 14. By Region - Global Autoimmune Disease Drug Revenue Market Share, 2018-2030
Figure 15. By Country - North America Autoimmune Disease Drug Revenue Market Share, 2018-2030
Figure 16. US Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Autoimmune Disease Drug Revenue Market Share, 2018-2030
Figure 20. Germany Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 21. France Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Autoimmune Disease Drug Revenue Market Share, 2018-2030
Figure 28. China Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 32. India Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Autoimmune Disease Drug Revenue Market Share, 2018-2030
Figure 34. Brazil Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Autoimmune Disease Drug Revenue Market Share, 2018-2030
Figure 37. Turkey Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Autoimmune Disease Drug Revenue, (US$, Mn), 2018-2030
Figure 41. Abbott Laboratories Autoimmune Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Autoimmune Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AbbVie Autoimmune Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Eli Lilly Autoimmune Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bristol-Myers Squibb Autoimmune Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca plc Autoimmune Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. GlaxoSmithKline Autoimmune Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Roche Autoimmune Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Biogen Autoimmune Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Amgen Autoimmune Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
